• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性单纯性苔藓瘙痒强度及合并症的回顾性分析

A Retrospective Analysis of Itch Intensity and Comorbidities in Lichen Simplex Chronicus.

作者信息

Mashoudy Kayla D, Ye-Tay Joselyn, Kim Sarah, Khalil Nicole, Yosipovitch Gil

机构信息

Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, USA.

Department of Pediatrics, Nicklaus Children's Hospital, Miami, USA.

出版信息

Acta Derm Venereol. 2025 Sep 4;105:adv43776. doi: 10.2340/actadv.v105.43776.

DOI:10.2340/actadv.v105.43776
PMID:40908757
Abstract

Lichen simplex chronicus is a chronic pruritic skin condition that significantly impacts quality of life. This retrospective study analysed 125 patients with clinically confirmed lichen simplex chronicus seen at a tertiary academic centre to characterize itch severity, anatomical distribution, and associated comorbidities. Itch intensity was assessed using the Numerical Rating Scale (NRS), and clinical data were stratified by demographics and disease extent. Most patients (75%) reported moderate-to-severe itch (NRS 4-10), with nearly 90% experiencing daily pruritus and half reporting both daytime and nocturnal symptoms. The limbs were the most commonly affected sites. Comorbid conditions were frequent, including generalized anxiety disorder (50% vs ~3% in the US adult population), major depressive disorder (44% vs ~8%), hypertension (61% vs ~45%), and type 2 diabetes (30% vs ~11%). Patients with multiple-lesion lichen simplex chronicus had significantly higher itch severity (mean NRS 7.81 vs 7.08, p = 0.001) and were more likely to be female (81% vs 46%, p = 0.002) compared with those with localized disease. These findings highlight the high symptom burden and frequent co-occurrence of psychiatric and metabolic comorbidities in lichen simplex chronicus. Thus, early identification and management of psychiatric, neurological, and metabolic conditions may improve outcomes for patients with lichen simplex chronicus.

摘要

慢性单纯性苔藓是一种慢性瘙痒性皮肤病,严重影响生活质量。这项回顾性研究分析了在一家三级学术中心就诊的125例临床确诊为慢性单纯性苔藓的患者,以确定瘙痒严重程度、解剖分布及相关合并症。使用数字评定量表(NRS)评估瘙痒强度,并根据人口统计学和疾病范围对临床数据进行分层。大多数患者(75%)报告有中度至重度瘙痒(NRS 4-10),近90%的患者每天都有瘙痒,半数患者报告有白天和夜间症状。四肢是最常受累的部位。合并症很常见,包括广泛性焦虑障碍(50%,而美国成年人口中约为3%)、重度抑郁症(44%,而美国成年人口中约为8%)、高血压(61%,而美国成年人口中约为45%)和2型糖尿病(30%,而美国成年人口中约为11%)。与局限性疾病患者相比,多病灶慢性单纯性苔藓患者的瘙痒严重程度明显更高(平均NRS 7.81对7.08,p = 0.001),且更可能为女性(81%对46%,p = 0.002)。这些发现凸显了慢性单纯性苔藓患者的高症状负担以及精神和代谢合并症的频繁共现。因此,早期识别和管理精神、神经和代谢疾病可能会改善慢性单纯性苔藓患者的治疗效果。

相似文献

1
A Retrospective Analysis of Itch Intensity and Comorbidities in Lichen Simplex Chronicus.慢性单纯性苔藓瘙痒强度及合并症的回顾性分析
Acta Derm Venereol. 2025 Sep 4;105:adv43776. doi: 10.2340/actadv.v105.43776.
2
Efficacy and safety of rilzabrutinib in patients with moderate-to-severe atopic dermatitis: 16-week results from a proof-of-concept phase II clinical trial.瑞扎布替尼治疗中重度特应性皮炎患者的疗效和安全性:一项概念验证性II期临床试验的16周结果
Br J Dermatol. 2025 Aug 18;193(3):424-433. doi: 10.1093/bjd/ljaf156.
3
Long-term (68 weeks) administration of nemolizumab and topical corticosteroids for prurigo nodularis in patients aged ≥ 13 years: efficacy and safety data from a phase II/III study.≥13岁结节性痒疹患者长期(68周)使用奈莫利单抗和外用皮质类固醇:一项II/III期研究的疗效和安全性数据
Br J Dermatol. 2025 Jun 20;193(1):56-65. doi: 10.1093/bjd/ljaf045.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
Ruxolitinib Cream Monotherapy Improved Symptoms and Quality of Life in Adults and Adolescents with Mild-to-Moderate Atopic Dermatitis: Patient-Reported Outcomes from Two Phase III Studies.芦可替尼乳膏单药治疗改善了轻至中度特应性皮炎成人和青少年的症状及生活质量:两项III期研究的患者报告结果
Am J Clin Dermatol. 2025 Jan;26(1):121-137. doi: 10.1007/s40257-024-00901-z. Epub 2024 Nov 15.
6
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic Dermatitis.与安慰剂(“Measure Up 1”和“Measure Up 2”研究)及度普利尤单抗(“Heads Up”研究)相比,乌帕替尼可快速改善瘙痒并清除皮肤症状:三项针对中度至重度特应性皮炎患者的3期临床试验结果
Dermatol Ther (Heidelb). 2025 Jun 2. doi: 10.1007/s13555-025-01443-w.
9
Pruritus in atopic dermatitis: a cross-sectional study of adult patients from a tertiary university hospital in São Paulo, Brazil.特应性皮炎中的瘙痒:对巴西圣保罗一所三级大学医院成年患者的横断面研究。
An Bras Dermatol. 2025 Jul-Aug;100(4):101093. doi: 10.1016/j.abd.2024.09.006. Epub 2025 Mar 11.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.